Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 215 articles: HTML format

Single Articles

November 2021
1. EGGERS KM, James SK, Lindahl B
   Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
   Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
   PubMed    
   
   
   
2. PITT B, Ferreira JP, Zannad F
   Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
   Eur Heart J. 2021 Nov 12. pii: 6425576. doi: 10.1093.
   PubMed    
   
   
   
3. WINTHER S, Schmidt SE, Knuuti J, Bottcher M, et al
   Selecting the right cohorts and endpoints for the validation of pre-test probability models for obstructive coronary artery disease.
   Eur Heart J. 2021;42:4402-4403.
   PubMed    
   
   
   
4. DERIMAY F, Finet G, Rioufol G
   Coronary artery stenosis prediction does not mean coronary artery stenosis obstruction.
   Eur Heart J. 2021;42:4401.
   PubMed    
   
   
   
5. EGIDY ASSENZA G, Dimopoulos K, Budts W, Donti A, et al
   Management of acute cardiovascular complications in pregnancy.
   Eur Heart J. 2021;42:4224-4240.
   PubMed     Abstract available
   
   
   October 2021
6. BIAN L, Fang Z, Qian H, Wu Z, et al
   Dumbbell on the heart: two giant left coronary artery aneurysms in an adolescent.
   Eur Heart J. 2021;42:4195.
   PubMed    
   
   
   
7. TSUDA K, Kanzaki Y, Hoshiga M
   Early cardiac magnetic resonance leads to diagnose the etiology of myocardial infarction with non-obstructive coronary arteries.
   Eur Heart J. 2021 Oct 18. pii: 6400298. doi: 10.1093.
   PubMed    
   
   
   
8. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
   Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
   Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
   Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
   Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. CREA F
    The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients.
    Eur Heart J. 2021;42:3807-3811.
    PubMed    
    
    
    September 2021
11. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    PubMed    
    
    
    
12. GRINES CL, Mehta S
    ST-segment elevation myocardial infarction management: great strides but still room for improvement.
    Eur Heart J. 2021 Sep 16. pii: 6371299. doi: 10.1093.
    PubMed    
    
    
    
13. SINHA A, Rahman H, Webb A, Shah AM, et al
    Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Eur Heart J. 2021 Sep 16. pii: 6371296. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. JAFFER FA, Mehilli J, Escaned J
    Left main coronary disease at the bifurcation: should the pendulum swing back towards the provisional stenting approach?
    Eur Heart J. 2021 Sep 13. pii: 6368942. doi: 10.1093.
    PubMed    
    
    
    
15. MESSIKA-ZEITOUN D, Hibbert B, Chan V
    'Primary' percutaneous mitral valve repair in patients with acute myocardial infarction: is it ready for primetime?
    Eur Heart J. 2021 Sep 2. pii: 6362540. doi: 10.1093.
    PubMed    
    
    
    August 2021
16. HABERMAN D, Estevez-Loureiro R, Benito-Gonzalez T, Denti P, et al
    Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction.
    Eur Heart J. 2021 Aug 31. pii: 6360026. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. CREA F
    Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
    Eur Heart J. 2021;42:3109-3113.
    PubMed    
    
    
    
18. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    PubMed     Abstract available
    
    
    
19. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    PubMed     Abstract available
    
    
    
20. WERESKI R, Kimenai DM, Bularga A, Taggart C, et al
    Risk factors for type 1 and type 2 myocardial infarction.
    Eur Heart J. 2021 Aug 25. pii: 6357312. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. LUSEBRINK E, Massberg S, Orban M
    The lack of evidence-based therapeutic strategies for left ventricular unloading during venoarterial extracorporeal membrane oxygenation therapy calls for randomized trials.
    Eur Heart J. 2021;42:3105-3106.
    PubMed    
    
    
    
22. KLOECKNER M, Guihaire J, Hascoet S
    Congestive pulmonary oedema during venoarterial extracorporeal membrane oxygenation support: a plea for balloon atrial septostomy.
    Eur Heart J. 2021;42:3103-3104.
    PubMed    
    
    
    
23. BOSCH J, Lonn EM, Jung H, Zhu J, et al
    Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
    Eur Heart J. 2021;42:2995-3007.
    PubMed     Abstract available
    
    
    
24. LEONE AM, Liuzzo G
    No blossom for fractional flow reserve in FLOWER-MI.
    Eur Heart J. 2021;42:2971-2972.
    PubMed    
    
    
    
25. YANG H, Chang S, Qian J, Ge J, et al
    A gigantic coronary pseudoaneurysm in a 60-year-old man.
    Eur Heart J. 2021;42:3027.
    PubMed    
    
    
    
26. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. WANG N, Sun Y, Zhang H, Wang B, et al
    Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease.
    Eur Heart J. 2021 Aug 10. pii: 6347324. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. DE CATERINA R, Brown DL
    Interpreting myocardial infarction analyses in ISCHEMIA: separating facts from fallacy.
    Eur Heart J. 2021 Aug 5. pii: 6342393. doi: 10.1093.
    PubMed    
    
    
    July 2021
29. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed    
    
    
    
31. CREA F
    Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis.
    Eur Heart J. 2021;42:2715-2719.
    PubMed    
    
    
    
32. WACKER J, Malaspinas I, Vallee JP, Beghetti M, et al
    Regression of coronary arteries aneurysms 6 months after multisystem inflammatory syndrome in children (MIS-C).
    Eur Heart J. 2021;42:2803.
    PubMed    
    
    
    
33. ANSELMO A, Frank D, Papa L, Viviani Anselmi C, et al
    Myocardial hypoxic stress mediates functional cardiac extracellular vesicle release.
    Eur Heart J. 2021;42:2780-2792.
    PubMed     Abstract available
    
    
    
34. STRANDBERG TE, Kovanen PT
    Coronary artery disease: 'gout' in the artery?
    Eur Heart J. 2021;42:2761-2764.
    PubMed    
    
    
    
35. PRADHAN AD
    Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?
    Eur Heart J. 2021;42:2776-2779.
    PubMed    
    
    
    
36. ANGELINI F, Bocchino PP, Imazio M
    Colchicine and coronary artery disease: a virtuous adoption.
    Eur Heart J. 2021;42:2796-2797.
    PubMed    
    
    
    
37. BOUABDALLAOUI N, Blondeau L, Tardif JC
    Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
    Eur Heart J. 2021;42:2800-2801.
    PubMed    
    
    
    
38. MADHAVAN MV, Howard JP, Naqvi A, Ben-Yehuda O, et al
    Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
    Eur Heart J. 2021;42:2643-2654.
    PubMed     Abstract available
    
    
    
39. ABDELWAHED YS, Schatz AS, Landmesser U, Skurk C, et al
    'Small bifurcation?' CT myocardial mass volume measurements change therapeutic strategy in coronary artery disease.
    Eur Heart J. 2021;42:2713-2714.
    PubMed    
    
    
    
40. CREA F
    The growing complexity of the number one killer: ischaemic heart disease.
    Eur Heart J. 2021;42:2513-2517.
    PubMed    
    
    
    
41. OIKONOMOU EK, Van Dijk D, Parise H, Suchard MA, et al
    A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST).
    Eur Heart J. 2021;42:2536-2548.
    PubMed     Abstract available
    
    
    
42. COLLET JP, Thiele H
    Lesson learnt from the new 2020 ESC guidelines on non-ST-segment elevation acute coronary syndrome: when clinical judgement precedes and overpasses weak recommendations. 2020 non-ST-segment elevation acute coronary syndrome guidelines on pre-treatment
    Eur Heart J. 2021;42:2607-2608.
    PubMed    
    
    
    
43. COLLET JP, Thiele H
    Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Eur Heart J. 2021;42:2611-2612.
    PubMed    
    
    
    
44. SANNA GD
    Lesson learnt from the new 2020 ESC guidelines on NSTE-ACS: when clinical judgement precedes and overpasses weak recommendations.
    Eur Heart J. 2021;42:2605-2606.
    PubMed    
    
    
    
45. KOW CS, Zaihan AF, Hasan SS
    Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Eur Heart J. 2021;42:2609-2610.
    PubMed    
    
    
    
46. SHENOY S, Singh A, Acharya T
    Incidental isolated septal infarct in a young patient with colon cancer.
    Eur Heart J. 2021;42:2613.
    PubMed    
    
    
    
47. 
    SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    Eur Heart J. 2021;42:2455-2467.
    PubMed     Abstract available
    
    
    
48. OZKAN J
    Patient Perspective: Maria George founder of INOCA International.
    Eur Heart J. 2021;42:2408-2410.
    PubMed    
    
    
    June 2021
49. VOLPE M, Patrono C
    The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk.
    Eur Heart J. 2021;42:2329-2330.
    PubMed    
    
    
    
50. CREA F
    The Universal Definition of Heart Failure, risk prediction in cardiogenic shock, artificial intelligence in cardiac allograft rejection, and the genetics of dilated cardiomyopathy.
    Eur Heart J. 2021;42:2317-2320.
    PubMed    
    
    
    
51. HUBER K
    Scores for outcome prediction in patients admitted with cardiogenic shock.
    Eur Heart J. 2021;42:2353-2355.
    PubMed    
    
    
    
52. LUSEBRINK E, Massberg S, Orban M
    The multiple options of left atrial and ventricular venting during veno-arterial extra-corporeal membrane oxygenation: practical considerations.
    Eur Heart J. 2021;42:2399-2400.
    PubMed    
    
    
    
53. POZZI M, Grinberg D, Rioufol G
    Percutaneous left ventricular unloading in veno-arterial extracorporeal membrane oxygenation.
    Eur Heart J. 2021;42:2397-2398.
    PubMed    
    
    
    
54. VOLPE M, Patrono C
    Vulnerable non-culprit coronary plaques: are they worth treating?
    Eur Heart J. 2021;42:2233-2234.
    PubMed    
    
    
    
55. COLLET JP, Thiele H
    Major bleeding and the ADP-binding enzyme creatine kinase in non-ST-segment elevation acute coronary syndromes.
    Eur Heart J. 2021;42:2313-2314.
    PubMed    
    
    
    
56. BREWSTER LM
    Because of its association with major bleeding the ADP-binding enzyme creatine kinase should be estimated in studies of patients treated for non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
    Eur Heart J. 2021;42:2311-2312.
    PubMed    
    
    
    May 2021
57. BULLUCK H, Paradies V, Barbato E, Baumbach A, et al
    Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardio
    Eur Heart J. 2021 May 31. pii: 6290281. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. VARBO A, Nordestgaard BG
    Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
    Eur Heart J. 2021 May 23. pii: 6282433. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. VAN DER STOUWE JG, Boeddinghaus J, Mueller C
    Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
    Eur Heart J. 2021 May 23. pii: 6282428. doi: 10.1093.
    PubMed    
    
    
    
60. HOLT A, Blanche P, McGettigan P, Lamberts M, et al
    Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis.
    Eur Heart J. 2021 May 23. pii: 6282429. doi: 10.1093.
    PubMed    
    
    
    
61. 
    Corrigendum to: Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials.
    Eur Heart J. 2021 May 23. pii: 6282430. doi: 10.1093.
    PubMed    
    
    
    
62. VOLZ S, Redfors B, Angeras O, Ioanes D, et al
    Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Eur Heart J. 2021 May 23. pii: 6282431. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2021
63. JANSEN TPJ, Damman P, Nijveldt R
    Diagnostic necessity of cardiac MRI in myocardial infarction with no obstructive coronary arteries: an illustration.
    Eur Heart J. 2021 Apr 14. pii: 6225950. doi: 10.1093.
    PubMed    
    
    
    
64. CREA F
    Guidelines on myocardial infarction, novel therapeutic targets in post-infarction remodelling, and a debate on the ISCHEMIA trial.
    Eur Heart J. 2021;42:1277-1280.
    PubMed    
    
    
    
65. BODEN WE, Stone PH
    To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
    Eur Heart J. 2021;42:1394-1400.
    PubMed    
    
    
    
66. GERSH BJ, Boden WE, Bhatt DL, Stone PH, et al
    To stent or not to stent? Treating angina after ISCHEMIA-introduction.
    Eur Heart J. 2021;42:1387-1388.
    PubMed    
    
    
    
67. GERSH BJ, Bhatt DL
    To stent or not to stent? Treating angina after ISCHEMIA-the impact of the ISCHEMIA trial on the indications for angiography and revascularization in patients with stable coronary artery disease.
    Eur Heart J. 2021;42:1389-1393.
    PubMed    
    
    
    
68. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
    The association between coronary graft patency and clinical status in patients with coronary artery disease.
    Eur Heart J. 2021;42:1433-1441.
    PubMed     Abstract available
    
    
    
69. RADICO F, Zimarino M, De Caterina R
    Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?
    Eur Heart J. 2021;42:1444-1445.
    PubMed    
    
    
    
70. SCHRODER J, Prescott E
    Coronary flow velocity reserve adds prognostic information beyond presence or absence of non-obstructive coronary atherosclerosis.
    Eur Heart J. 2021;42:1442-1443.
    PubMed    
    
    
    
71. SECHTEM U, Ong P
    Coronary stenoses in patients suspected to have obstructive coronary artery disease: the exemption rather than the rule!
    Eur Heart J. 2021;42:1412-1414.
    PubMed    
    
    
    
72. WINTHER S, Schmidt SE, Rasmussen LD, Juarez Orozco LE, et al
    Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease.
    Eur Heart J. 2021;42:1401-1411.
    PubMed     Abstract available
    
    
    
73. COLLET JP, Thiele H, Barbato E, Barthelemy O, et al
    2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1289-1367.
    PubMed    
    
    
    
74. BARBATO E, Mehilli J, Sibbing D, Siontis GCM, et al
    Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients present
    Eur Heart J. 2021;42:1368-1378.
    PubMed    
    
    
    
75. BARTHELEMY O, Jobs A, Meliga E, Mueller C, et al
    Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1379-1386.
    PubMed    
    
    
    
76. DING D, Huang J, Westra J, Cohen DJ, et al
    Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions.
    Eur Heart J. 2021 Apr 5. pii: 6211340. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2021
77. FRIGERIO M
    Fausto Rovelli (1918-2021): the father of Italian cardiology, pioneer of early reperfusion therapy for acute myocardial infarction, and unforgettable master for his hospital colleagues.
    Eur Heart J. 2021 Mar 29. pii: 6199127. doi: 10.1093.
    PubMed    
    
    
    
78. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. ZHANG H, Xiao Z, Yang P, Hu J, et al
    Ruptured coronary artery aneurysm mimicking as a giant mediastinal mass.
    Eur Heart J. 2021;42:1183.
    PubMed    
    
    
    
80. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
    Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
    Eur Heart J. 2021;42:1019-1034.
    PubMed     Abstract available
    
    
    
81. MARENZI G, Cosentino N, Cardinale D
    Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
    Eur Heart J. 2021;42:1035-1037.
    PubMed    
    
    
    
82. ERDMANN J, van der Laan SW
    Unfolding and disentangling coronary vascular disease through genome-wide association studies.
    Eur Heart J. 2021;42:934-937.
    PubMed    
    
    
    
83. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    PubMed     Abstract available
    
    
    
84. IBANEZ B, Roque D, Price S
    The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care.
    Eur Heart J. 2021;42:884-895.
    PubMed    
    
    
    
85. WANG X, Yan C
    Progression of artery aneurysm after transcatheter closure of coronary artery fistula.
    Eur Heart J. 2021;42:918.
    PubMed    
    
    
    February 2021
86. CEGLAREK U, Schellong P, Rosolowski M, Scholz M, et al
    The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
    Eur Heart J. 2021 Feb 27. pii: 6153946. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. REFFO E, Stritoni V, Di Salvo G
    Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.
    Eur Heart J. 2021 Feb 20. pii: 6145783. doi: 10.1093.
    PubMed    
    
    
    
88. BOUABDALLAOUI N, Tardif JC
    Initiation of low-dose colchicine early after myocardial infarction.
    Eur Heart J. 2021 Feb 4. pii: 6127594. doi: 10.1093.
    PubMed    
    
    
    
89. HARTIALA JA, Han Y, Jia Q, Hilser JR, et al
    Genome-wide analysis identifies novel susceptibility loci for myocardial infarction.
    Eur Heart J. 2021 Feb 3. pii: 6126843. doi: 10.1093/eurheartj/ehaa1040.
    PubMed     Abstract available
    
    
    
90. BERGONTI M
    Emergency Room visits in the COVID-19 pandemic.
    Eur Heart J. 2021;42:369-370.
    PubMed    
    
    
    January 2021
91. XING Y, Dai N, Li H
    Is abnormal function with troponin T elevation definitely myocardial infarction?
    Eur Heart J. 2021 Jan 30. pii: 6124030. doi: 10.1093.
    PubMed    
    
    
    
92. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    PubMed     Abstract available
    
    
    
93. LUNARDI M, Onuma Y, Serruys PW
    Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
    Eur Heart J. 2021 Jan 27. pii: 6121205. doi: 10.1093.
    PubMed    
    
    
    
94. VRACHATIS DA, Giannopoulos GV, Deftereos SG
    Colchicine administered early in acute myocardial infarction: ready, set ... go?
    Eur Heart J. 2021 Jan 22. pii: 6106966. doi: 10.1093.
    PubMed    
    
    
    
95. 
    Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2021;42:322.
    PubMed    
    
    
    
96. JOBS A, Collet JP, Thiele H
    Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?
    Eur Heart J. 2021;42:353-354.
    PubMed    
    
    
    
97. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    PubMed    
    
    
    
98. SCHRODER J, Michelsen MM, Mygind ND, Suhrs HE, et al
    Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Eur Heart J. 2021;42:228-239.
    PubMed     Abstract available
    
    
    
99. RAY KK
    Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care.
    Eur Heart J. 2021;42:253-256.
    PubMed    
    
    
    
100. DAVIES A, Fox K, Galassi AR, Banai S, et al
     Management of refractory angina: an update.
     Eur Heart J. 2021;42:269-283.
     PubMed     Abstract available
     
     
     
101. SICARI R
     The curious incident of CFVR in clinical practice.
     Eur Heart J. 2021;42:240-242.
     PubMed    
     
     
     
102. PLAT J, Strandberg TE, Gylling H
     Intestinal cholesterol and phytosterol absorption and the risk of coronary artery disease.
     Eur Heart J. 2021;42:281-282.
     PubMed    
     
     
     
103. HELGADOTTIR A, Thorleifsson G, Stefansson K
     Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers.
     Eur Heart J. 2021;42:283-284.
     PubMed    
     
     
     
104. ABDELWAHED YS, Wurster TH, Landmesser U, Leistner DM, et al
     Culprit mistaken: development of a traumatic coronary aneurysm after mismatched culprit lesion-PCI for plaque rupture.
     Eur Heart J. 2021;42:287.
     PubMed    
     
     
     
105. KOLBE M, Lopez-Ayala P, Mueller C
     Women who experience a myocardial infarction at a young age.
     Eur Heart J. 2021 Jan 19. pii: 6104220. doi: 10.1093.
     PubMed    
     
     
     
106. CHATTOPADHYAY S, John J
     Women experiencing myocardial infarction at a young age have worse outcomes compared with men: only for non-cardiovascular deaths and when treated inadequately?
     Eur Heart J. 2021 Jan 17. pii: 6103003. doi: 10.1093.
     PubMed    
     
     
     
107. HOLT A, Blanche P, Zareini B, Rajan D, et al
     Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study.
     Eur Heart J. 2021 Jan 11. pii: 6082772. doi: 10.1093/eurheartj/ehaa1058.
     PubMed     Abstract available
     
     
     
108. MONACO C, Cole J
     Does a myocardial infarction boost your (B cell) memory?
     Eur Heart J. 2021 Jan 4. pii: 6061967. doi: 10.1093/eurheartj/ehaa1059.
     PubMed    
     
     
     
109. LIN S, Chen S, Zhe Z
     Model assessment: new measures should be known and traditional measures should be accurately interpreted.
     Eur Heart J. 2021;42:134-135.
     PubMed    
     
     
     
110. AMINORROAYA A, Tajdini M, Masoudkabir F
     Time for clinicians to revisit their perspectives on C-statistic.
     Eur Heart J. 2021;42:132-133.
     PubMed    
     
     
     
111. LAWLER PR, Bhatt DL, Godoy LC, Luscher TF, et al
     Targeting cardiovascular inflammation: next steps in clinical translation.
     Eur Heart J. 2021;42:113-131.
     PubMed     Abstract available
     
     
     December 2020
112. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
     Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
     Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
     Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
     Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
     PubMed     Abstract available
     
     
     
114. FIOLET ATL, Nidorf SM, Cornel JH
     Colchicine for secondary prevention in coronary disease.
     Eur Heart J. 2020 Dec 21. pii: 6042608. doi: 10.1093.
     PubMed    
     
     
     
115. KYAW T, Loveland P, Kanellakis P, Cao A, et al
     Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.
     Eur Heart J. 2020 Dec 18. pii: 6041767. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. KOTANIDIS CP, Antoniades C
     Selfies in cardiovascular medicine: welcome to a new era of medical diagnostics.
     Eur Heart J. 2020;41:4412-4414.
     PubMed    
     
     
     
117. ROY R, Koch WJ
     Adding another GRK to the fire of heart failure.
     Eur Heart J. 2020 Dec 7. pii: 6025474. doi: 10.1093.
     PubMed    
     
     
     
118. LI L, Fu W, Gong X, Chen Z, et al
     The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction.
     Eur Heart J. 2020 Dec 6. pii: 6024960. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2020
119. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
     Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
     Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. ORWAT S, Diller GP
     Congenital heart defects as an intrinsic additional risk factor for the occurrence and outcome of myocardial infarction.
     Eur Heart J. 2020 Nov 22. pii: 5998317. doi: 10.1093.
     PubMed    
     
     
     
121. FEDCHENKO M, Mandalenakis Z, Giang KW, Rosengren A, et al
     Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study.
     Eur Heart J. 2020 Nov 21. pii: 5997447. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. MUNZEL T, Hahad O, Daiber A
     The dark side of nocturnal light pollution. Outdoor light at night increases risk of coronary heart disease.
     Eur Heart J. 2020 Nov 21. pii: 5998262. doi: 10.1093.
     PubMed    
     
     
     
123. BOHM M, Mahfoud F
     J-curve revisited.
     Eur Heart J. 2020;41:4283.
     PubMed    
     
     
     
124. LIEW CH, McEvoy JW
     The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
     Eur Heart J. 2020;41:4284-4285.
     PubMed    
     
     
     
125. SUN S, Cao W, Ge Y, Ran J, et al
     Outdoor light at night and risk of coronary heart disease among older adults: a prospective cohort study.
     Eur Heart J. 2020 Nov 17. pii: 5986682. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. ARSENOS P, Antoniou CK, Gatzoulis KA
     Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
     Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.
     PubMed    
     
     
     
127. NEUVILLERS L, Veugeois A, Didier J, Paul JF, et al
     Myocardial infarction with non-obstructive coronary artery revealing a heart tumour.
     Eur Heart J. 2020 Nov 13. pii: 5981589. doi: 10.1093.
     PubMed    
     
     
     
128. COLLET JP, Thiele H
     Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
     Eur Heart J. 2020 Nov 13. pii: 5981490. doi: 10.1093.
     PubMed    
     
     
     
129. NICHOLLS M
     Australia and colchicine for coronary heart disease.
     Eur Heart J. 2020 Nov 10. pii: 5961660. doi: 10.1093.
     PubMed    
     
     
     
130. VERDECCHIA P, Angeli F, Cavallini C
     Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
     Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
     PubMed    
     
     
     
131. LUSCHER TF
     The sooner, the better: anti-inflammation in acute myocardial infarction.
     Eur Heart J. 2020;41:4100-4102.
     PubMed    
     
     
     
132. VRACHATIS DA, Deftereos S, Stefanini GG
     STEMI in COVID-19 patients: thrombolysis-first approach could yield more risk than benefit.
     Eur Heart J. 2020;41:4141-4142.
     PubMed    
     
     
     
133. ZHANG L, Fan Y, Lu Z
     Compromised STEMI reperfusion strategy in the era of COVID-19 pandemic: pros and cons.
     Eur Heart J. 2020;41:4143.
     PubMed    
     
     
     
134. CANNON CP
     Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.
     Eur Heart J. 2020;41:4124-4126.
     PubMed    
     
     
     
135. MELE M, Casavecchia G, Ieva R, Brunetti ND, et al
     Diagnosis of acute myocardial infarction in the time of the COVID-19 pandemic.
     Eur Heart J. 2020 Nov 4. pii: 5956256. doi: 10.1093.
     PubMed    
     
     
     October 2020
136. BATKAI S, Genschel C, Viereck J, Rump S, et al
     CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.
     Eur Heart J. 2020 Oct 22. pii: 5934677. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. LANDMESSER U, Luscher TF
     Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3.
     Eur Heart J. 2020;41:3946-3948.
     PubMed    
     
     
     
138. TOKGOZOGLU L, Catapano AL
     Can EPA evaporate plaques?
     Eur Heart J. 2020;41:3933-3935.
     PubMed    
     
     
     
139. BALLANTYNE CM, Virani SS
     Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
     Eur Heart J. 2020;41:3910-3912.
     PubMed    
     
     
     
140. CHANDRASEKAR B, Alanbaei M
     Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis.
     Eur Heart J. 2020 Oct 14. pii: 5922862. doi: 10.1093.
     PubMed    
     
     
     
141. BONNET M, Champagnac A, Lantelme P, Harbaoui B, et al
     Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
     Eur Heart J. 2020;41:3863-3864.
     PubMed    
     
     
     
142. TWEET MS
     Sex differences among young individuals with myocardial infarction.
     Eur Heart J. 2020 Oct 13. pii: 5921646. doi: 10.1093.
     PubMed    
     
     
     
143. DEFILIPPIS EM, Collins BL, Singh A, Biery DW, et al
     Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry.
     Eur Heart J. 2020 Oct 13. pii: 5921645. doi: 10.1093.
     PubMed     Abstract available
     
     
     
144. LIUZZO G, Patrono C
     Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
     Eur Heart J. 2020 Oct 7. pii: 5918829. doi: 10.1093.
     PubMed    
     
     
     
145. BOLLI R
     Cell therapy for acute myocardial infarction: Requiescat in Pace.
     Eur Heart J. 2020;41:3711-3714.
     PubMed    
     
     
     
146. LANSKY A, Grubman D, Scheller B
     Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis.
     Eur Heart J. 2020;41:3729-3731.
     PubMed    
     
     
     
147. STOREY RF
     The long journey of individualizing antiplatelet therapy after acute coronary syndromes.
     Eur Heart J. 2020;41:3546-3548.
     PubMed    
     
     
     
148. LIUZZO G, Pedicino D, Vinci R, Crea F, et al
     CD8 lymphocytes and plaque erosion: a new piece in the jigsaw.
     Eur Heart J. 2020;41:3561-3563.
     PubMed    
     
     
     
149. BABER U, Dangas G, Angiolillo DJ, Cohen DJ, et al
     Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
     Eur Heart J. 2020;41:3533-3545.
     PubMed     Abstract available
     
     
     September 2020
150. PARODI G, Sanna GD, Saba PS
     Understanding the complex interplay between coronary artery disease and Takotsubo syndrome: not all swans are white.
     Eur Heart J. 2020;41:3268-3270.
     PubMed    
     
     
     
151. WALTERSCHEID B, Nguyen J, Tarbox M, Eshak N, et al
     Clopidogrel-induced sweet syndrome: severe dermatological complication after percutaneous coronary intervention.
     Eur Heart J. 2020 Sep 4. pii: 5901663. doi: 10.1093.
     PubMed    
     
     
     
152. LIBERALE L, Gorog DA
     Low-grade endotoxaemia and platelets: a deadly aggregation.
     Eur Heart J. 2020;41:3166-3168.
     PubMed    
     
     
     
153. SCHUPKE S, Kastrati A
     Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.
     Eur Heart J. 2020;41:3153-3155.
     PubMed    
     
     
     August 2020
154. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
     Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
     Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
     PubMed     Abstract available
     
     
     
155. TUNON J, Steg PG, Bhatt DL, Bittner VA, et al
     Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
     Eur Heart J. 2020 Aug 21. pii: 5895197. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. KHAN S
     Mast cell tryptase level should be checked in all patients with suspected Kounis syndrome.
     Eur Heart J. 2020;41:3018.
     PubMed    
     
     
     
157. CHATTERJEE NA, Tikkanen JT, Albert CM
     The electrocardiogram and sudden death: capturing electrical physiology and arrhythmic substrate.
     Eur Heart J. 2020;41:2911-2912.
     PubMed    
     
     
     
158. ASATRYAN B, Roten L, Reichlin T
     Identifying coronary artery disease patients at risk for sudden and/or arrhythmic death: remaining limitations of the electrocardiogram.
     Eur Heart J. 2020;41:2911-2912.
     PubMed    
     
     
     July 2020
159. WEINGARTNER O, Patel SB, Lutjohann D
     It's time to personalize and optimize lipid-lowering therapy.
     Eur Heart J. 2020;41:2629-2631.
     PubMed    
     
     
     
160. HOWARD JP, Arnold AD, Ahmad Y
     Bias, heterogeneity, and uncertainty in meta-analysis.
     Eur Heart J. 2020;41:2712.
     PubMed    
     
     
     
161. LI Y, Yan L, Shui S, Han X, et al
     Choriocarcinoma metastasis in the left atrium.
     Eur Heart J. 2020;41:2628.
     PubMed    
     
     
     
162. TAN HL, van Dongen LH, Zimmerman DS
     Sudden cardiac death in young patients with diabetes: a call to study additional causes beyond ischaemic heart disease.
     Eur Heart J. 2020;41:2707-2709.
     PubMed    
     
     
     
163. TU S, Westra J, Adjedj J, Wijns W, et al
     Physiological assessment of non-culprit stenoses during acute coronary syndromes.
     Eur Heart J. 2020;41:2598.
     PubMed    
     
     
     
164. WACKER J, Malaspinas I, Aggoun Y, Bordessoule A, et al
     Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
     Eur Heart J. 2020;41:3103.
     PubMed    
     
     
     June 2020
165. JAYARAJ R, Kumaraswamy C, Shaw P
     Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
     Eur Heart J. 2020 Jun 26. pii: 5863013. doi: 10.1093.
     PubMed    
     
     
     
166. STIEKEMA LCA, Hovingh GK, Stroes ESG
     The therapeutic age paradox coming to an end.
     Eur Heart J. 2020;41:2259-2261.
     PubMed    
     
     
     
167. PAVASINI R, D'Ascenzo F, Campo G
     Moving forward from statistical to clinical considerations regarding complete revascularization.
     Eur Heart J. 2020;41:2225.
     PubMed    
     
     
     
168. JOBS A, Schwarzer G, Thiele H
     Conclusions of complete revascularization meta-analysis are challenged by state-of-the-art methods.
     Eur Heart J. 2020;41:2223-2224.
     PubMed    
     
     
     
169. THYGESEN K, Jaffe AS
     Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically.
     Eur Heart J. 2020;41:2217-2219.
     PubMed    
     
     
     
170. KONDAPALLI L, Moslehi J, Bonaca MP
     Inflammation begets inflammation: cancer and acute MI.
     Eur Heart J. 2020;41:2194-2196.
     PubMed    
     
     
     
171. DUSI V, De Ferrari GM, Schwartz PJ
     There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias.
     Eur Heart J. 2020;41:2180-2182.
     PubMed    
     
     
     
172. OLSHANSKY B
     The electrocardiogram: are we at the dawn of a new era?
     Eur Heart J. 2020;41:2000-2002.
     PubMed    
     
     
     May 2020
173. BJORNSTAD JL, Bendz B
     Periprocedural myocardial injury in the EXCEL trial.
     Eur Heart J. 2020;41:1703.
     PubMed    
     
     
     
174. HESS CN, Hiatt WR
     Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back.
     Eur Heart J. 2020;41:1650-1652.
     PubMed    
     
     
     April 2020
175. LUSCHER TF
     Sex and gender and cardiovascular medicine: impact in diabetes, acute coronary syndromes, and heart failure.
     Eur Heart J. 2020;41:1311-1314.
     PubMed    
     
     
     March 2020
176. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
     The muddy waters of the J-curve and coronary revascularization.
     Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
     PubMed    
     
     
     
177. KIM WC, Sumaya W, Elkhateeb OE
     Fibroelastoma presenting with recurrent myocardial infarction and diagnosed with intracoronary imaging: a novel intracoronary image of fibroelastoma.
     Eur Heart J. 2020 Mar 2. pii: 6157022. doi: 10.1093.
     PubMed    
     
     
     
178. AHMAD Y, Howard JP, Arnold AD, Cook CM, et al
     Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
     Eur Heart J. 2020 Mar 2. pii: 5771278. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. KLEBER ME, Delgado GE, Marz W
     LDL receptor traffic: in the fast lane.
     Eur Heart J. 2020;41:1054-1056.
     PubMed    
     
     
     February 2020
180. LABRECQUE JA, Kaufman JS, Huang JY
     Genetic instruments with too many strings: acknowledging pleiotropy and population structure in Mendelian randomization studies.
     Eur Heart J. 2020;41:892-893.
     PubMed    
     
     
     
181. SINNAEVE P, Van de Werf F
     Primary PCI and the indistinct 120 min time limit.
     Eur Heart J. 2020;41:867-869.
     PubMed    
     
     
     
182. GIANNOPOULOS AA, Gaemperli O
     The power of myocardial blood flow reserve in personalizing management of patients with stable coronary artery disease. Is it time to move on from percentage of ischaemia?
     Eur Heart J. 2020;41:769-771.
     PubMed    
     
     
     January 2020
183. LUSCHER TF
     Chronic coronary syndromes: expanding the spectrum and natural history of ischaemic heart disease.
     Eur Heart J. 2020;41:333-336.
     PubMed    
     
     
     
184. IANNACCONE M, Brilakis ES, Boccuzzi GG
     An App for complex PCI solutions.
     Eur Heart J. 2020;41:342-344.
     PubMed    
     
     
     
185. AL'AREF SJ, Maliakal G, Singh G, van Rosendael AR, et al
     Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.
     Eur Heart J. 2020;41:359-367.
     PubMed     Abstract available
     
     
     
186. KNUUTI J, Wijns W, Saraste A, Capodanno D, et al
     2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
     Eur Heart J. 2020;41:407-477.
     PubMed    
     
     
     
187. SORBETS E, Fox KM, Elbez Y, Danchin N, et al
     Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
     Eur Heart J. 2020;41:347-356.
     PubMed     Abstract available
     
     
     
188. PRATI F, Romagnoli E, Gatto L, La Manna A, et al
     Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study.
     Eur Heart J. 2020;41:383-391.
     PubMed     Abstract available
     
     
     
189. HILVO M, Meikle PJ, Pedersen ER, Tell GS, et al
     Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
     Eur Heart J. 2020;41:371-380.
     PubMed     Abstract available
     
     
     
190. ALI ZA, McEntegart M, Hill JM, Spratt JC, et al
     Intravascular lithotripsy for treatment of stent underexpansion secondary to severe coronary calcification.
     Eur Heart J. 2020;41:485-486.
     PubMed    
     
     
     
191. LEE HS, Chang M, Piccinelli M, Koo BK, et al
     Complete regression of coronary atherosclerosis.
     Eur Heart J. 2020;41:332.
     PubMed    
     
     
     
192. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
     The year in cardiology: coronary interventions.
     Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
     PubMed    
     
     
     
193. SCHNORBUS B, Daiber A, Jurk K, Warnke S, et al
     Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study.
     Eur Heart J. 2020 Jan 3. pii: 5695774. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2019
194. KOGAME N, Serruys PW, Onuma Y
     Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.
     Eur Heart J. 2019 Dec 23. pii: 5686015. doi: 10.1093.
     PubMed    
     
     
     
195. MALMBORG M, Schmiegelow MDS, Norgaard CH, Munch A, et al
     Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
     Eur Heart J. 2019 Dec 20. pii: 5682397. doi: 10.1093.
     PubMed     Abstract available
     
     
     
196. LOPEZ-JIMENEZ F, Gersh BJ
     Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
     Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
     PubMed    
     
     
     November 2019
197. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
     Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
     Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
     PubMed    
     
     
     
198. LUSCHER TF
     Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
     Eur Heart J. 2019;40:3579-3582.
     PubMed    
     
     
     
199. SINNAEVE PR, Schwartz GG, Wojdyla DM, Alings M, et al
     Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
     Eur Heart J. 2019 Nov 16. pii: 5626150. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2019
200. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
     Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
     Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
     PubMed     Abstract available
     
     
     
201. BJORKLUND E, Nielsen SJ, Hansson EC, Karlsson M, et al
     Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
     Eur Heart J. 2019 Oct 22. pii: 5602556. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. IBANEZ B
     And fibrinolysis became pharmacoinvasive.
     Eur Heart J. 2019 Oct 12. pii: 5586502. doi: 10.1093.
     PubMed    
     
     
     August 2019
203. TAYAL B, Fruelund P, Sogaard P, Riahi S, et al
     Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study.
     Eur Heart J. 2019 Aug 26. pii: 5554632. doi: 10.1093.
     PubMed     Abstract available
     
     
     
204. LUSCHER TF
     Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.
     Eur Heart J. 2019;40:2549-2552.
     PubMed    
     
     
     
205. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
     Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
     Eur Heart J. 2019;40:2595-2604.
     PubMed     Abstract available
     
     
     June 2019
206. MEHRA MR, Vaduganathan M, Fu M, Ferreira JP, et al
     A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
     Eur Heart J. 2019 Jun 25. pii: 5522950. doi: 10.1093.
     PubMed     Abstract available
     
     
     
207. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
     Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
     Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
     PubMed     Abstract available
     
     
     
208. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
     Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
     Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. GENTILLE LORENTE DI
     Coconut atrium: a rare entity to cause pulmonary hypertension.
     Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
     PubMed    
     
     
     May 2019
210. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
     Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
     Eur Heart J. 2019 May 22. pii: 5492739. doi: 10.1093.
     PubMed     Abstract available
     
     
     
211. DEVEREAUX PJ, Szczeklik W
     Myocardial injury after non-cardiac surgery: diagnosis and management.
     Eur Heart J. 2019 May 16. pii: 5490290. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2019
212. JONES DA, Rathod KS, Koganti S, Lim P, et al
     The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention: an observational study from the Pan-London PCI (BCIS) Registry using an
     Eur Heart J. 2019 Apr 10. pii: 5443278. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2019
213. GRABHER F, Hamm W, Massberg S, Orban M, et al
     Uncommon cause of progressive dyspnoea 12 years after coronary artery bypass surgery.
     Eur Heart J. 2019 Mar 12. pii: 5377349. doi: 10.1093.
     PubMed    
     
     
     January 2019
214. KHAN AA, Lip GYH
     Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
     Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
     PubMed    
     
     
     November 2018
215. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
     Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
     Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: